Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses

Antiviral Research

Volumn 124, Issue , 2015, Pages 110-121

  Villareal, Valerie A ^a   Rodgers, Mary A ^a,b   Costello, Deirdre A ^a   Yang, Priscilla L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Antiviral therapy; Dengue virus; Flavivirus; Hepatitis C virus; Host targeted antiviral; Lipids

Indexed keywords

LIPID; ANTIVIRUS AGENT;

CELL PROLIFERATION; DENGUE VIRUS; ENERGY; GENE EXPRESSION; GENE REPLICATION; GENOME; HEPACIVIRUS; HEPATITIS C VIRUS; HOST CELL; LIPID METABOLISM; LIPID TRANSPORT; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPOSIUM; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS INHIBITION; VIRUS RELEASE; VIRUS REPLICATION; BIOSYNTHESIS; DENGUE; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; HEPATITIS C; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTIVIRAL AGENTS; DENGUE; DENGUE VIRUS; DRUG DISCOVERY; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPID METABOLISM; LIPIDS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84947914805     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.10.013     Document Type: Review

References (95)

1. V. Agnello, G. Abel, M. Elfahal, G.B. Knight, and Q.X. Zhang Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor Proc. Natl. Acad. Sci. U. S. A. 96 1999 12766 12771
2. H. Aizaki, K. Morikawa, M. Fukasawa, H. Hara, Y. Inoue, H. Tani, K. Saito, M. Nishijima, K. Hanada, Y. Matsuura, M.M. Lai, T. Miyamura, T. Wakita, and T. Suzuki Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection J. Virol. 82 2008 5715 5724
3. T.E. Aktepe, H. Pham, and J.M. Mackenzie Differential utilisation of ceramide during replication of the flaviviruses West Nile and dengue virus Virology 484 2015 241 250
4. A. Albecka, S. Belouzard, A. Op de Beeck, V. Descamps, L. Goueslain, J. Bertrand-Michel, F. Terce, G. Duverlie, Y. Rouille, and J. Dubuisson Role of low-density lipoprotein receptor in the hepatitis C virus life cycle Hepatology 55 2012 998 1007
5. P. Andre, F. Komurian-Pradel, S. Deforges, M. Perret, J.L. Berland, M. Sodoyer, S. Pol, C. Brechot, G. Paranhos-Baccala, and V. Lotteau Characterization of low- and very-low-density hepatitis C virus RNA-containing particles J. Virol. 76 2002 6919 6928
6. T. Bader, J. Fazili, M. Madhoun, C. Aston, D. Hughes, S. Rizvi, K. Seres, and M. Hasan Fluvastatin inhibits hepatitis C replication in humans Am. J. Gastroenterol. 103 2008 1383 1389
7. B. Bartosch, G. Verney, M. Dreux, P. Donot, Y. Morice, F. Penin, J.M. Pawlotsky, D. Lavillette, and F.L. Cosset An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies J. Virol. 79 2005 8217 8229
8. W.J. Benga, S.E. Krieger, M. Dimitrova, M.B. Zeisel, M. Parnot, J. Lupberger, E. Hildt, G. Luo, J. McLauchlan, T.F. Baumert, and C. Schuster Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles Hepatology 51 2010 43 53
9. C. Berger, I. Romero-Brey, D. Radujkovic, R. Terreux, M. Zayas, D. Paul, C. Harak, S. Hoppe, M. Gao, F. Penin, V. Lohmann, and R. Bartenschlager Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication Gastroenterology 147 2014 1094 1105 e25
10. K.L. Berger, J.D. Cooper, N.S. Heaton, R. Yoon, T.E. Oakland, T.X. Jordan, G. Mateu, A. Grakoui, and G. Randall Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication Proc. Natl. Acad. Sci. 106 2009 7577 7582
11. F.A. Carvalho, F.A. Carneiro, I.C. Martins, I. Assuncao-Miranda, A.F. Faustino, R.M. Pereira, P.T. Bozza, M.A. Castanho, R. Mohana-Borges, A.T. Da Poian, and N.C. Santos Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins J. Virol. 86 2012 2096 2108
12. M.T. Catanese, K. Uryu, M. Kopp, T.J. Edwards, L. Andrus, W.J. Rice, M. Silvestry, R.J. Kuhn, and C.M. Rice Ultrastructural analysis of hepatitis C virus particles Proc. Natl. Acad. Sci. U. S. A. 110 2013 9505 9510
13. F.F. Chao, D.L. Stiers, and J.A. Ontko Hepatocellular triglyceride synthesis and transfer to lipid droplets and nascent very low density lipoproteins J. Lipid Res. 27 1986 1174 1181
14. V. Chukkapalli, K.L. Berger, S.M. Kelly, M. Thomas, A. Deiters, and G. Randall Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides Virology 476 2015 168 179
15. E.G. Cormier, F. Tsamis, F. Kajumo, R.J. Durso, J.P. Gardner, and T. Dragic CD81 is an entry coreceptor for hepatitis C virus Proc. Natl. Acad. Sci. U. S. A. 101 2004 7270 7274
16. O. Diaz, F. Delers, M. Maynard, S. Demignot, F. Zoulim, J. Chambaz, C. Trepo, V. Lotteau, and P. Andre Preferential association of hepatitis C virus with apolipoprotein B48-containing lipoproteins J. Gen. Virol. 87 2006 2983 2991
17. M. Dreux, B. Boson, S. Ricard-Blum, J. Molle, D. Lavillette, B. Bartosch, E.I. Pecheur, and F.L. Cosset The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus J. Biol. Chem. 282 2007 32357 32369
18. D. Egger, B. Wolk, R. Gosert, L. Bianchi, H.E. Blum, D. Moradpour, and K. Bienz Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex J. Virol. 76 2002 5974 5984
19. M.J. Evans, C.M. Rice, and S.P. Goff Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication Proc. Natl. Acad. Sci. U. S. A. 101 2004 13038 13043
20. E. Fahy, D. Cotter, M. Sud, and S. Subramaniam Lipid classification, structures and tools Biochim. Biophys. Acta 1811 2011 637 647
21. E. Fahy, S. Subramaniam, H.A. Brown, C.K. Glass, A.H. Merrill Jr., R.C. Murphy, C.R. Raetz, D.W. Russell, Y. Seyama, W. Shaw, T. Shimizu, F. Spener, G. van Meer, M.S. VanNieuwenhze, S.H. White, J.L. Witztum, and E.A. Dennis A comprehensive classification system for lipids J. Lipid Res. 46 2005 839 861
22. E. Fahy, S. Subramaniam, R.C. Murphy, M. Nishijima, C.R. Raetz, T. Shimizu, F. Spener, G. van Meer, M.J. Wakelam, and E.A. Dennis Update of the LIPID MAPS comprehensive classification system for lipids J. Lipid Res. 50 2009 S9 S14 Suppl
23. A.F. Faustino, F.A. Carvalho, I.C. Martins, M.A. Castanho, R. Mohana-Borges, F.C. Almeida, A.T. Da Poian, and N.C. Santos Dengue virus capsid protein interacts specifically with very low-density lipoproteins Nanomedicine Nanotechnol. Biol. Med. 10 2014 247 255
24. K.A. Forde, C. Law, R. O'Flynn, and D.E. Kaplan Do statins reduce hepatitis C RNA titers during routine clinical use? World J. Gastroenterol. WJG 15 2009 5020 5027
25. J. Garcia Cordero, M. Leon Juarez, Y.M.J.A. Gonzalez, L. Cedillo Barron, and B. Gutierrez Castaneda Caveolin-1 in lipid rafts interacts with dengue virus NS3 during polyprotein processing and replication in HMEC-1 cells PloS One 9 2014 e90704
26. P. Gastaminza, G. Cheng, S. Wieland, J. Zhong, W. Liao, and F.V. Chisari Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion J. Virol. 82 2008 2120 2129
27. H. Glaumann, and G. Dallner Lipid composition and turnover of rough and smooth microsomal membranes in rat liver J. Lipid Res. 9 1968 720 729
28. C. Grief, R. Galler, L.M. Cortes, and O.M. Barth Intracellular localisation of dengue-2 RNA in mosquito cell culture using electron microscopic in situ hybridisation Arch. Virol. 142 1997 2347 2357
29. X. Han, and R.W. Gross Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples Mass Spectrom. Rev. 24 2005 367 412
30. N.S. Heaton, R. Perera, K.L. Berger, S. Khadka, D.J. Lacount, R.J. Kuhn, and G. Randall Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis Proc. Natl. Acad. Sci. 107 2010 17345 17350
31. N.S. Heaton, and G. Randall Dengue virus-induced autophagy regulates lipid metabolism Cell Host Microbe 8 2010 422 432
32. E. Herker, C. Harris, C. Hernandez, A. Carpentier, K. Kaehlcke, A.R. Rosenberg, R.V. Farese Jr., and M. Ott Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1 Nat. Med. 16 2010 1295 1298
33. D.W. Hilgemann, S. Feng, and C. Nasuhoglu The complex and intriguing lives of PIP2 with ion channels and transporters Sci STKE. 2001 Dec 4 2001(111), re19
34. T. Hishiki, Y. Shimizu, R. Tobita, K. Sugiyama, K. Ogawa, K. Funami, Y. Ohsaki, T. Fujimoto, H. Takaku, T. Wakita, T.F. Baumert, Y. Miyanari, and K. Shimotohno Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms J. Virol. 84 2010 12048 12057
35. H. Huang, F. Sun, D.M. Owen, W. Li, Y. Chen, M. Gale Jr., and J. Ye Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins Proc. Natl. Acad. Sci. U. S. A. 104 2007 5848 5853
36. M. Ikeda, K. Abe, M. Yamada, H. Dansako, K. Naka, and N. Kato Different anti-HCV profiles of statins and their potential for combination therapy with interferon Hepatology 44 2006 117 125
37. Ira, and L.J. Johnston Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes Biochimica Biophysica Acta 1778 2008 185 197
38. Ira, S. Zou, D.M. Ramirez, S. Vanderlip, W. Ogilvie, Z.J. Jakubek, and L.J. Johnston Enzymatic generation of ceramide induces membrane restructuring: correlated AFM and fluorescence imaging of supported bilayers J. Struct. Biol. 168 2009 78 89
39. P.T. Ivanova, S.B. Milne, D.S. Myers, and H.A. Brown Lipidomics: a mass spectrometry based systems level analysis of cellular lipids Curr. Opin. Chem. Biol. 13 2009 526 531
40. I. Johnston, and L.J. Johnston Ceramide promotes restructuring of model raft membranes Langmuir ACS J. Surf. Colloids 22 2006 11284 11289
41. J. Junjhon, J.G. Pennington, T.J. Edwards, R. Perera, J. Lanman, and R.J. Kuhn Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells J. Virol. 88 2014 4687 4697
42. S.B. Kapadia, H. Barth, T. Baumert, J.A. McKeating, and F.V. Chisari Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I J. Virol. 81 2007 374 383
43. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc. Natl. Acad. Sci. U. S. A. 102 2005 2561 2566
44. S.J. Kridel, F. Axelrod, N. Rozenkrantz, and J.W. Smith Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity Cancer Res. 64 2004 2070 2075
45. C. Lee, H. Ma, J.Q. Hang, V. Leveque, E.H. Sklan, M. Elazar, K. Klumpp, and J.S. Glenn The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein Virology 414 2011 10 18
46. C.J. Lee, H.R. Lin, C.L. Liao, and Y.L. Lin Cholesterol effectively blocks entry of flavivirus J. Virol. 82 2008 6470 6480
47. Y.R. Lee, H.Y. Hu, S.H. Kuo, H.Y. Lei, Y.S. Lin, T.M. Yeh, C.C. Liu, and H.S. Liu Dengue virus infection induces autophagy: an in vivo study J. Biomed. Sci. 20 2013 65
48. Y.R. Lee, H.Y. Lei, M.T. Liu, J.R. Wang, S.H. Chen, Y.F. Jiang-Shieh, Y.S. Lin, T.M. Yeh, C.C. Liu, and H.S. Liu Autophagic machinery activated by dengue virus enhances virus replication Virology 374 2008 240 248
49. Y. Li, C. Kakinami, Q. Li, B. Yang, and H. Li Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI PloS One 8 2013 e70390
50. J.M. Mackenzie, A.A. Khromykh, and R.G. Parton Cholesterol manipulation by West Nile virus perturbs the cellular immune response Cell Host Microbe 2 2007 229 239
51. C. Mancone, C. Steindler, L. Santangelo, G. Simonte, C. Vlassi, M.A. Longo, G. D'Offizi, C. Di Giacomo, L.P. Pucillo, L. Amicone, M. Tripodi, and T. Alonzi Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins Gut 60 2011 378 386
52. M.A. Martin-Acebes, T. Merino-Ramos, A.B. Blazquez, J. Casas, E. Escribano-Romero, F. Sobrino, and J.C. Saiz The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis J. Virol. 88 2014 12041 12054
53. M. Martinez-Gutierrez, L.A. Correa-Londono, J.E. Castellanos, J.C. Gallego-Gomez, and J.E. Osorio Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2 PloS One 9 2014 e87412
54. I.C. Martins, F. Gomes-Neto, A.F. Faustino, F.A. Carvalho, F.A. Carneiro, P.T. Bozza, R. Mohana-Borges, M.A. Castanho, F.C. Almeida, N.C. Santos, and A.T. Da Poian The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif Biochem. J. 444 2012 405 415
55. T. Masaki, R. Suzuki, K. Murakami, H. Aizaki, K. Ishii, A. Murayama, T. Date, Y. Matsuura, T. Miyamura, T. Wakita, and T. Suzuki Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles J. Virol. 82 2008 7964 7976
56. R. Mateo, C.M. Nagamine, J. Spagnolo, E. Mendez, M. Rahe, M. Gale Jr., J. Yuan, and K. Kirkegaard Inhibition of cellular autophagy deranges dengue virion maturation J. Virol. 87 2013 1312 1321
57. J. McLauchlan, M.K. Lemberg, G. Hope, and B. Martoglio Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets EMBO J. 21 2002 3980 3988
58. N. Menzel, W. Fischl, K. Hueging, D. Bankwitz, A. Frentzen, S. Haid, J. Gentzsch, L. Kaderali, R. Bartenschlager, and T. Pietschmann MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles PLoS Pathog. 8 2012 e1002829
59. A. Merz, G. Long, M.S. Hiet, B. Brugger, P. Chlanda, P. Andre, F. Wieland, J. Krijnse-Locker, and R. Bartenschlager Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome J. Biol. Chem. 286 2011 3018 3032
60. Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno The lipid droplet is an important organelle for hepatitis C virus production Nat. Cell Biol. 9 2007 1089 1097
61. M. Monazahian, I. Bohme, S. Bonk, A. Koch, C. Scholz, S. Grethe, and R. Thomssen Low density lipoprotein receptor as a candidate receptor for hepatitis C virus J. Med. Virol. 57 1999 223 229
62. J. Munger, B.D. Bennett, A. Parikh, X.J. Feng, J. McArdle, H.A. Rabitz, T. Shenk, and J.D. Rabinowitz Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy Nat. Biotechnol. 26 2008 1179 1186
63. A.C. Newton Lipid activation of protein kinases J. Lipid Res. 50 2009 S266 S271 Suppl
64. S.U. Nielsen, M.F. Bassendine, A.D. Burt, C. Martin, W. Pumeechockchai, and G.L. Toms Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients J. Virol. 80 2006 2418 2428
65. A.M. Nour, Y. Li, J. Wolenski, and Y. Modis Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses PLoS Pathog. 9 2013 e1003585
66. J.G. O'Leary, J.L. Chan, C.M. McMahon, and R.T. Chung Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial Hepatology 45 2007 895 898
67. D.M. Owen, H. Huang, J. Ye, and M. Gale Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor Virology 394 2009 99 108
68. J. Pena, and E. Harris Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway PloS One 7 2012 e38202
69. R. Perera, C. Riley, G. Isaac, A.S. Hopf-Jannasch, R.J. Moore, K.W. Weitz, L. Pasa-Tolic, T.O. Metz, J. Adamec, and R.J. Kuhn Dengue virus infection perturbs lipid homeostasis in infected mosquito cells PLoS Pathog. 8 2012 e1002584
70. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani Binding of hepatitis C virus to CD81 Science 282 1998 938 941
71. M.K. Poh, G. Shui, X. Xie, P.Y. Shi, M.R. Wenk, and F. Gu U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication Antivir. Res. 93 2012 191 198
72. M. Quintavalle, S. Sambucini, V. Summa, L. Orsatti, F. Talamo, R. De Francesco, and P. Neddermann Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors J. Biol. Chem. 282 2007 5536 5544
73. V. Reghellin, L. Donnici, S. Fenu, V. Berno, V. Calabrese, M. Pagani, S. Abrignani, F. Peri, R. De Francesco, and P. Neddermann NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIalpha complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes Antimicrob. Agents Chemother. 58 2014 7128 7140
74. S. Reiss, I. Rebhan, P. Backes, I. Romero-Brey, H. Erfle, P. Matula, L. Kaderali, M. Poenisch, H. Blankenburg, M.-S. Hiet, T. Longerich, S. Diehl, F. Ramirez, T. Balla, K. Rohr, A. Kaul, S. Bühler, R. Pepperkok, T. Lengauer, M. Albrecht, R. Eils, P. Schirmacher, V. Lohmann, and R. Bartenschlager Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment Cell Host Microbe 9 2011 32 45
75. M.A. Rodgers, A. Saghatelian, and P.L. Yang Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profiling J. Am. Chem. Soc. 131 2009 5030 5031
76. M.A. Rodgers, V.A. Villareal, E.A. Schaefer, L.F. Peng, K.E. Corey, R.T. Chung, and P.L. Yang Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus J. Am. Chem. Soc. 134 2012 6896 6899
77. A.E. Rolim, R. Henrique-Araujo, E.G. Ferraz, F.K. de Araujo Alves Dultra, and L.G. Fernandez Lipidomics in the study of lipid metabolism: current perspectives in the omic sciences Gene 554 2015 131 139
78. I. Romero-Brey, A. Merz, A. Chiramel, J.Y. Lee, P. Chlanda, U. Haselman, R. Santarella-Mellwig, A. Habermann, S. Hoppe, S. Kallis, P. Walther, C. Antony, J. Krijnse-Locker, and R. Bartenschlager Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication PLoS Pathog. 8 2012 e1003056
79. C. Rothwell, A. Lebreton, C. Young Ng, J.Y. Lim, W. Liu, S. Vasudevan, M. Labow, F. Gu, and L.A. Gaither Cholesterol biosynthesis modulation regulates dengue viral replication Virology 389 2009 8 19
80. B. Sainz Jr., N. Barretto, D.N. Martin, N. Hiraga, M. Imamura, S. Hussain, K.A. Marsh, X. Yu, K. Chayama, W.A. Alrefai, and S.L. Uprichard Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor Nat. Med. 18 2012 281 285
81. M.M. Samsa, J.A. Mondotte, N.G. Iglesias, I. Assuncao-Miranda, G. Barbosa-Lima, A.T. Da Poian, P.T. Bozza, and A.V. Gamarnik Dengue virus capsid protein usurps lipid droplets for viral particle formation PLoS Pathog. 5 2009 e1000632
82. R. Soto-Acosta, P. Bautista-Carbajal, G.H. Syed, A. Siddiqui, and R.M. Del Angel Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus Antivir. Res. 109 2014 132 140
83. R. Soto-Acosta, C. Mosso, M. Cervantes-Salazar, H. Puerta-Guardo, F. Medina, L. Favari, J.E. Ludert, and R.M. del Angel The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity Virology 442 2013 132 147
84. W.C. Tang, R.J. Lin, C.L. Liao, and Y.L. Lin Rab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replication J. Virol. 88 2014 6793 6804
85. H. Tani, M. Shiokawa, Y. Kaname, H. Kambara, Y. Mori, T. Abe, K. Moriishi, and Y. Matsuura Involvement of ceramide in the propagation of Japanese encephalitis virus J. Virol. 84 2010 2798 2807
86. L.B. Tanner, C. Chng, X.L. Guan, Z. Lei, S.G. Rozen, and M.R. Wenk Lipidomics identifies a requirement for peroxisomal function during influenza virus replication J. Lipid Res. 55 2014 1357 1365
87. P.G. Teoh, Z.S. Huang, W.L. Pong, P.C. Chen, and H.N. Wu Maintenance of dimer conformation by the dengue virus core protein alpha4-alpha4' helix pair is critical for nucleocapsid formation and virus production J. Virol. 88 2014 7998 8015
88. F.H. Vaillancourt, M. Brault, L. Pilote, N. Uyttersprot, E.T. Gaillard, J.H. Stoltz, B.L. Knight, L. Pantages, M. McFarland, S. Breitfelder, T.T. Chiu, L. Mahrouche, A.M. Faucher, M. Cartier, M.G. Cordingley, R.C. Bethell, H. Jiang, P.W. White, and G. Kukolj Evaluation of phosphatidylinositol-4-kinase IIIalpha as a hepatitis C virus drug target J. Virol. 86 2012 11595 11607
89. H.M. van der Schaar, M.J. Rust, C. Chen, H. van der Ende-Metselaar, J. Wilschut, X. Zhuang, and J.M. Smit Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells PLoS Pathog. 4 2008 e1000244
90. H.M. van der Schaar, M.J. Rust, B.L. Waarts, H. van der Ende-Metselaar, R.J. Kuhn, J. Wilschut, X. Zhuang, and J.M. Smit Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking J. Virol. 81 2007 12019 12028
91. S. Welsch, S. Miller, I. Romero-Brey, A. Merz, C.K. Bleck, P. Walther, S.D. Fuller, C. Antony, J. Krijnse-Locker, and R. Bartenschlager Composition and three-dimensional architecture of the dengue virus replication and assembly sites Cell Host Microbe 5 2009 365 375
92. D. Yamane, D.R. McGivern, E. Wauthier, M. Yi, V.J. Madden, C. Welsch, I. Antes, Y. Wen, P.E. Chugh, C.E. McGee, D.G. Widman, I. Misumi, S. Bandyopadhyay, S. Kim, T. Shimakami, T. Oikawa, J.K. Whitmire, M.T. Heise, D.P. Dittmer, C.C. Kao, S.M. Pitson, A.H. Merrill Jr., L.M. Reid, and S.M. Lemon Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation Nat. Med. 20 2014 927 935
93. J. Ye, C. Wang, R. Sumpter Jr., M.S. Brown, J.L. Goldstein, and M. Gale Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc. Natl. Acad. Sci. U. S. A. 100 2003 15865 15870
94. E. Zaitseva, S.T. Yang, K. Melikov, S. Pourmal, and L.V. Chernomordik Dengue virus ensures its fusion in late endosomes using compartment-specific lipids PLoS Pathog. 6 2010 e1001131
95. J.H. Zhang, L. Ge, W. Qi, L. Zhang, H.H. Miao, B.L. Li, M. Yang, and B.L. Song The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake J. Biol. Chem. 286 2011 25088 25097